Lineage Cell Therapeutics, Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Red day on Thursday for Lineage Cell Therapeutics, Inc. stock after losing 2.75%
(Updated on May 16, 2024)
The Lineage Cell Therapeutics, Inc. stock price fell by -2.75% on the last day (Thursday, 16th May 2024) from $1.09 to $1.06. During the last trading day the stock fluctuated 5.71% from a day low at $1.05 to a day high of $1.11. The price has fallen in 6 of the last 10 days but is still up by 0.95% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -261 thousand shares and in total, 715 thousand shares were bought and sold for approximately $757.69 thousand.
The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $1.05 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Lineage Cell Therapeutics, Inc. stock with a 90% probability to be traded between $1.06 and $1.49 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
LCTX Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lineage Cell Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.11 and $1.23. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, May 06, 2024, and so far it has fallen -18.46%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Lineage Cell Therapeutics, Inc. stock
Lineage Cell Therapeutics, Inc. finds support from accumulated volume at $1.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0600 between high and low, or 5.71%. For the last week the stock has had daily average volatility of 7.68%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (LCTX) For The Upcoming Trading Day Of Friday 17th
For the upcoming trading day on Friday, 17th we expect Lineage Cell Therapeutics, Inc. to open at $1.07, and during the day (based on 14 day Average True Range), to move between $0.96 and $1.16, which gives a possible trading interval of +/-$0.0972 (+/-9.17%) up or down from last closing price. If Lineage Cell Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 18.35% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $1.05 (0.94%) than the resistance at $1.09 (2.83%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Lineage Cell Therapeutics, Inc. stock A Buy?
Lineage Cell Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -2.632 Sell Candidate Unchanged
Predicted Opening Price for Lineage Cell Therapeutics, Inc. of Friday, May 17, 2024
| Fair opening price May 17, 2024 | Current price |
|---|---|
| $1.07 ( 1.26%) | $1.06 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for LCTX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.13 | 6.92 % | |
| R2 | 1.11 | 4.76 % | ||
| R1 | 1.10 | 3.42 % | ||
| Current price: | 1.06 | |||
| Support | S1 | 1.05 | -0.90 % | |
| S2 | 1.04 | -2.24 % | ||
| S3 | 1.01 | -4.40 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.30 | 22.64 % | |
| R2 | 1.29 | 21.70 % | ||
| R1 | 1.09 | 2.83 % | ||
| Current price | 1.06 | |||
| Support | S1 | 1.05 | -0.94% | |
| S2 | 1.04 | -1.89% | ||
| S3 | 1.03 | -2.83% |
LCTX Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 15, 2003 | Dec 15, 2003 | Dec 15, 2003 | $0.0800 | 5.56% |
FAQ
Click here for our free guide on how to buy Lineage Cell Therapeutics, Inc. Stock.
